Cargando…
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell car...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770480/ https://www.ncbi.nlm.nih.gov/pubmed/33384916 http://dx.doi.org/10.1016/j.jbo.2020.100344 |
_version_ | 1783629518557151232 |
---|---|
author | Owari, Takuya Miyake, Makito Nakai, Yasushi Tanaka, Nobumichi Itami, Yoshitaka Hirao, Shuya Momose, Hitoshi Nakagawa, Yoshinori Iida, Kouta Maesaka, Fumisato Shimizu, Takuto Iemura, Yusuke Matsumoto, Yoshihiro Kuwada, Masaomi Otani, Takeshi Otsuka, Kenji Okajima, Eijiro Hosokawa, Yukinari Okamura, Ryosuke Fujimoto, Kiyohide |
author_facet | Owari, Takuya Miyake, Makito Nakai, Yasushi Tanaka, Nobumichi Itami, Yoshitaka Hirao, Shuya Momose, Hitoshi Nakagawa, Yoshinori Iida, Kouta Maesaka, Fumisato Shimizu, Takuto Iemura, Yusuke Matsumoto, Yoshihiro Kuwada, Masaomi Otani, Takeshi Otsuka, Kenji Okajima, Eijiro Hosokawa, Yukinari Okamura, Ryosuke Fujimoto, Kiyohide |
author_sort | Owari, Takuya |
collection | PubMed |
description | OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell carcinoma (RCC) and PCa vs urothelial carcinoma (UC)), poor performance status (PS), visceral metastasis, high Glasgow-prognostic score (GPS), elevated neutrophil-to-lymphocyte ratio (NLR). The aim of this study was to externally validate and further improve the performance of the B-FOM score. METHODS: The external validation cohort comprised 309 patients with GU cancer with bone metastasis from multiple institutions. Clinical factors were analyzed using Kaplan-Meier method and COX regression hazard model. Performance of a modified B-FOM score was compared to that of other scoring models by the Kaplan-Meier method and the area under the curve (AUC) of receiver operating characteristic curves. RESULTS: The median follow-up period of development and validation cohort were 25 and 17 months, respectively. Kaplan-Meier curve demonstrated that the type of primary tumor (RCC and UC vs PCa), poor PS, presence of visceral metastasis, high GPS, elevated NLR were significantly associated with shorter cancer-specific survival. Risk groups were successfully stratified by the modified B-FOM score classification. Moreover, the AUC of the modified B-FOM scoring model for predicting mortality at 6, 12, and 24 months were 0.895, 0.856, and 0.815, respectively, which were the highest among evaluated models. CONCLUSIONS: The B-FOM scoring model is a simple and accurate prediction tool. By using this scoring model at the time of the diagnosis of bone metastasis in patients with GU cancers, an individualized optimal treatment strategy can be selected. |
format | Online Article Text |
id | pubmed-7770480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77704802020-12-30 External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy Owari, Takuya Miyake, Makito Nakai, Yasushi Tanaka, Nobumichi Itami, Yoshitaka Hirao, Shuya Momose, Hitoshi Nakagawa, Yoshinori Iida, Kouta Maesaka, Fumisato Shimizu, Takuto Iemura, Yusuke Matsumoto, Yoshihiro Kuwada, Masaomi Otani, Takeshi Otsuka, Kenji Okajima, Eijiro Hosokawa, Yukinari Okamura, Ryosuke Fujimoto, Kiyohide J Bone Oncol Research Article OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell carcinoma (RCC) and PCa vs urothelial carcinoma (UC)), poor performance status (PS), visceral metastasis, high Glasgow-prognostic score (GPS), elevated neutrophil-to-lymphocyte ratio (NLR). The aim of this study was to externally validate and further improve the performance of the B-FOM score. METHODS: The external validation cohort comprised 309 patients with GU cancer with bone metastasis from multiple institutions. Clinical factors were analyzed using Kaplan-Meier method and COX regression hazard model. Performance of a modified B-FOM score was compared to that of other scoring models by the Kaplan-Meier method and the area under the curve (AUC) of receiver operating characteristic curves. RESULTS: The median follow-up period of development and validation cohort were 25 and 17 months, respectively. Kaplan-Meier curve demonstrated that the type of primary tumor (RCC and UC vs PCa), poor PS, presence of visceral metastasis, high GPS, elevated NLR were significantly associated with shorter cancer-specific survival. Risk groups were successfully stratified by the modified B-FOM score classification. Moreover, the AUC of the modified B-FOM scoring model for predicting mortality at 6, 12, and 24 months were 0.895, 0.856, and 0.815, respectively, which were the highest among evaluated models. CONCLUSIONS: The B-FOM scoring model is a simple and accurate prediction tool. By using this scoring model at the time of the diagnosis of bone metastasis in patients with GU cancers, an individualized optimal treatment strategy can be selected. Elsevier 2020-12-13 /pmc/articles/PMC7770480/ /pubmed/33384916 http://dx.doi.org/10.1016/j.jbo.2020.100344 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Owari, Takuya Miyake, Makito Nakai, Yasushi Tanaka, Nobumichi Itami, Yoshitaka Hirao, Shuya Momose, Hitoshi Nakagawa, Yoshinori Iida, Kouta Maesaka, Fumisato Shimizu, Takuto Iemura, Yusuke Matsumoto, Yoshihiro Kuwada, Masaomi Otani, Takeshi Otsuka, Kenji Okajima, Eijiro Hosokawa, Yukinari Okamura, Ryosuke Fujimoto, Kiyohide External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title | External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title_full | External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title_fullStr | External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title_full_unstemmed | External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title_short | External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy |
title_sort | external validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified b-fom scoring model): comparison with other scoring models in terms of accuracy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770480/ https://www.ncbi.nlm.nih.gov/pubmed/33384916 http://dx.doi.org/10.1016/j.jbo.2020.100344 |
work_keys_str_mv | AT owaritakuya externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT miyakemakito externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT nakaiyasushi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT tanakanobumichi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT itamiyoshitaka externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT hiraoshuya externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT momosehitoshi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT nakagawayoshinori externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT iidakouta externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT maesakafumisato externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT shimizutakuto externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT iemurayusuke externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT matsumotoyoshihiro externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT kuwadamasaomi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT otanitakeshi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT otsukakenji externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT okajimaeijiro externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT hosokawayukinari externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT okamuraryosuke externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy AT fujimotokiyohide externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy |